ROCKET PHARMACEUTICALS, INC. Total Assets

Quick Answer

ROCKET PHARMACEUTICALS, INC. reported Total Assets of $330.45 million for the year ending 2025.

  • ROCKET PHARMACEUTICALS, INC. showed a decrease of -37.4% in Total Assets from 2024 to 2025.
  • This data is from ROCKET PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2015: $55.53 million | Q2 2015: $51.69 million | Q3 2015: $120.12 million | Q1 2016: $104.21 million | Q2 2016: $99.85 million | Q3 2016: $140.14 million | Q1 2017: $117.92 million | Q2 2017: $111.07 million | Q3 2017: $104.66 million | Q1 2018: $217.17 million | Q2 2018: $207.57 million | Q3 2018: $194.98 million | Q1 2019: $242.14 million | Q2 2019: $308.72 million | Q3 2019: $299.91 million | Q1 2020: $372.75 million | Q2 2020: $353.07 million | Q3 2020: $335.50 million | Q1 2021: $576.48 million | Q2 2021: $535.15 million | Q3 2021: $530.24 million | Q1 2022: $460.15 million | Q2 2022: $431.85 million | Q3 2022: $417.27 million | Q1 2023: $514.76 million | Q2 2023: $461.78 million | Q3 2023: $598.76 million | Q1 2024: $499.44 million | Q2 2024: $446.41 million | Q3 2024: $393.69 million | Q1 2025: $471.07 million | Q2 2025: $420.98 million | Q3 2025: $368.03 million.
  • Over the full 12 years of available data (2014 to 2025), ROCKET PHARMACEUTICALS, INC.'s Total Assets has grown by 5,886.4%.
  • Historical annual values: Fiscal year 2025: $330.45 million | Fiscal year 2024: $527.70 million | Fiscal year 2023: $566.34 million | Fiscal year 2022: $551.81 million | Fiscal year 2021: $497.02 million | Fiscal year 2020: $590.82 million | Fiscal year 2019: $372.12 million | Fiscal year 2018: $251.31 million | Fiscal year 2017: $20.15 million | Fiscal year 2016: $129.65 million | Fiscal year 2015: $113.32 million | Fiscal year 2014: $5.52 million.
  • Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: